These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7902479)

  • 1. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
    Waagstein F; Bristow MR; Swedberg K; Camerini F; Fowler MB; Silver MA; Gilbert EM; Johnson MR; Goss FG; Hjalmarson A
    Lancet; 1993 Dec; 342(8885):1441-6. PubMed ID: 7902479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group.
    Di Lenarda A; De Maria R; Gavazzi A; Gregori D; Parolini M; Sinagra G; Salvatore L; Longaro F; Bernobich E; Camerini F
    Heart; 1998 Apr; 79(4):337-44. PubMed ID: 9616339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
    Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial.
    Wiklund I; Waagstein F; Swedberg K; Hjalmarsson A
    Cardiovasc Drugs Ther; 1996 Jul; 10(3):361-8. PubMed ID: 8877080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
    Santostasi G; Marinato PG; Miraglia G; Egloff C; Maragno I
    Minerva Cardioangiol; 1994 Dec; 42(12):575-82. PubMed ID: 7753426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment.
    Andersson B; Hamm C; Persson S; Wikström G; Sinagra G; Hjalmarson A; Waagstein F
    J Am Coll Cardiol; 1994 May; 23(6):1397-404. PubMed ID: 8176099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group.
    DiLenarda A; Gregori D; Sinagra G; Lardieri G; Perkan A; Pinamonti B; Salvatore L; Secoli G; Zecchin M; Camerini F
    J Card Fail; 1996 Jun; 2(2):87-102. PubMed ID: 8798110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience.
    Shaddy RE; Tani LY; Gidding SS; Pahl E; Orsmond GS; Gilbert EM; Lemes V
    J Heart Lung Transplant; 1999 Mar; 18(3):269-74. PubMed ID: 10328154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy.
    Andersson B; Caidahl K; di Lenarda A; Warren SE; Goss F; Waldenström A; Persson S; Wallentin I; Hjalmarson A; Waagstein F
    Circulation; 1996 Aug; 94(4):673-82. PubMed ID: 8772687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.
    Waagstein F; Caidahl K; Wallentin I; Bergh CH; Hjalmarson A
    Circulation; 1989 Sep; 80(3):551-63. PubMed ID: 2548768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
    Engelmeier RS; O'Connell JB; Walsh R; Rad N; Scanlon PJ; Gunnar RM
    Circulation; 1985 Sep; 72(3):536-46. PubMed ID: 3893793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral metoprolol therapy in dilated cardiomyopathy: hemodynamic evidence for improved diastolic function accompanying amelioration of symptoms.
    Sethi KK; Nair M; Arora R; Khalilullah M
    Int J Cardiol; 1990 Dec; 29(3):317-22. PubMed ID: 2283189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study.
    Eichhorn EJ; Heesch CM; Barnett JH; Alvarez LG; Fass SM; Grayburn PA; Hatfield BA; Marcoux LG; Malloy CR
    J Am Coll Cardiol; 1994 Nov; 24(5):1310-20. PubMed ID: 7930255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
    De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
    Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of beta-blockers in left ventricular dysfunction and heart failure.
    Hjalmarson A; Kneider M; Waagstein F
    Drugs; 1997 Oct; 54(4):501-10. PubMed ID: 9339958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-exercise Doppler-echocardiographic haemodynamics in idiopathic dilated cardiomyopathy after metoprolol infusion.
    Perchet H; Pouillart F; Duval-Moulin AM; Heintz JF; Hittinger L; Castaigne A; Dubois-Randé JL
    Clin Sci (Lond); 1994 May; 86(5):523-9. PubMed ID: 8033506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
    Lancet; 1998 Apr; 351(9110):1180-1. PubMed ID: 9643698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.